Richard Bassett
We have observed 10 EP applications Richard Bassett has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF
- IPC classification:
- C07K 5/00, C07K 5/02, C07K 5/06, C07K 5/08, C07K 7/06
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ The patent has been granted
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
- IPC classification:
- A01K 67/027, C12N 15/00
- Applicant:
- University Of Missouri
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME
- IPC classification:
- A61K 38/38, A61K 38/55, A61K 47/48
- Applicant:
- Baxter Healthcare SA
- Applicant:
- Baxter International Inc
- Applicant:
- Baxalta GmbH
- Applicant:
- Baxalta Incorporated
- Agent:
- Hoffmann Eitle PartmbB
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ GRANT OF PATENT INTENDED
MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY
- IPC classification:
- A61K 47/00, C08B 37/00, C40B 50/00
- Applicant:
- Massachusetts Institute of Technology (MIT) Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ GRANT OF PATENT INTENDED
BIOADHESIVE DRUG DELIVERY COMPOSITIONS
- IPC classification:
- A61K 9/48
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
SYNTHESIS AND CHARACTERIZATION OF SECOND GENERATION BENZOFURANONE RING SUBSTITUTED NOSCAPINE ANALOGS
- IPC classification:
- A61K 31/4355, A61P 35/00, C07D 491/04
- Applicant:
- Georgia State University Research Foundation, Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
CARBOCYANINES FOR G-QUADRUPLEX DNA STABILIZATION AND TELOMERASE INHIBITION
- IPC classification:
- C12Q 1/68
- Applicant:
- Georgia State University Research Foundation, Inc.
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ EXAMINATION IN PROGRESS
METHOD FOR CONVERTING AND PRODUCING CARBONATE MINERALS FROM CARBON DIOXIDE USING RECOMBINANT BIOCATALYST
- IPC classification:
- C12N 9/88, C12P 3/00
- Applicant:
- Postech Academy-Industry Foundation
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ The patent has been granted
CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA
- IPC classification:
- A61K 31/74, A61P 1/00
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Agent:
- Eisenführ Speiser & Partner Patentanwälte Rechtsanwälte PartGmbB
- Status:
- █ EXAMINATION REQUESTED
Treatment of bladder dysfunction using liposomal botulinum toxin
- IPC classification:
- A61K 9/127, A61K 38/48, A61P 13/10
- Agent:
- Richard Bassett, Potter Clarkson LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN